Related Experiment Video
Updated: Dec 24, 2025

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Conditional Up-Regulation of SERCA2a Exacerbates RyR2-Dependent Ventricular and Atrial Arrhythmias
Bin Liu1,2, Qing Lou1, Heather Smith2
1Davis Heart and Lung Research Institute and Department of Physiology and Cell Biology, The Ohio State University, Columbus, OH 43210, USA.
Abstract:
Ryanodine receptor 2 (RyR2) and SERCA2a are two major players in myocyte calcium (Ca) cycling that are modulated physiologically, affected by disease and thus considered to be potential targets for cardiac disease therapy. However, how RyR2 and SERCA2a influence each others' activities, as well as the primary and secondary consequences of their combined manipulations remain controversial. In this study, we examined the effect of acute upregulation of SERCA2a on arrhythmogenesis by conditionally overexpressing SERCA2a in a mouse model featuring hyperactive RyR2s due to ablation of calsequestrin 2 (CASQ2). CASQ2 knock-out (KO) mice were crossbred with doxycycline (DOX)-inducible SERCA2a transgenic mice to generate KO-TG mice. In-vivo ECG studies have shown that induction of SERCA2a (DOX+) overexpression markedly exacerbated both ventricular and atrial arrhythmias in vivo, compared with uninduced KO-TG mice (DOX-). Consistent with that, confocal microscopy in both atrial and ventricular myocytes demonstrated that conditional upregulation of SERCA2a enhanced the rate of occurrence of diastolic Ca release events. Additionally, deep RNA sequencing identified 17 downregulated genes and 5 upregulated genes in DOX+ mice, among which Ppp1r13l, Clcn1, and Agt have previously been linked to arrhythmias. Our results suggest that conditional upregulation of SERCA2a exacerbates hyperactive RyR2-mediated arrhythmias by further elevating diastolic Ca release.
Insights
Upregulating SERCA2a in mice with hyperactive ryanodine receptor 2 (RyR2) worsened cardiac arrhythmias. This exacerbation was linked to increased diastolic calcium release events, suggesting a detrimental interaction between SERCA2a and RyR2 in heart rhythm disorders.
Area of Science:
- Cardiology
- Molecular Biology
- Genetics
Background:
- Ryanodine receptor 2 (RyR2) and SERCA2a are critical for cardiac calcium cycling.
- Dysregulation of these proteins is implicated in heart disease and arrhythmias.
- The interplay between RyR2 and SERCA2a in disease pathogenesis is not fully understood.
Purpose of the Study:
- To investigate the impact of SERCA2a upregulation on arrhythmogenesis in a mouse model with hyperactive RyR2.
- To elucidate the consequences of combined SERCA2a and RyR2 dysregulation on cardiac function.
Main Methods:
- Generation of a conditional mouse model by crossbreeding calsequestrin 2 (CASQ2) knock-out mice with doxycycline-inducible SERCA2a transgenic mice.
- In-vivo electrocardiogram (ECG) studies to assess arrhythmias.
- Confocal microscopy of atrial and ventricular myocytes.
- Deep RNA sequencing to identify gene expression changes.
Main Results:
- SERCA2a overexpression significantly exacerbated both ventricular and atrial arrhythmias compared to controls.
- Upregulation of SERCA2a increased the frequency of diastolic calcium release events in myocytes.
- RNA sequencing revealed altered expression of genes, including Ppp1r13l, Clcn1, and Agt, previously associated with arrhythmias.
Conclusions:
- Conditional SERCA2a upregulation worsens RyR2-mediated cardiac arrhythmias.
- The exacerbation is likely due to increased diastolic calcium release.
- This study highlights a detrimental interaction between SERCA2a and hyperactive RyR2 in promoting arrhythmias.
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Rheumatic Heart Disease I: Introduction
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Cardiomyopathy II: Dilated Cardiomyopathy

